Juvena: taking on aging with secreted proteins

With a $41 million series A round and growing enthusiasm for the human longevity therapeutics field, Juvena is using the momentum to advance a differentiated discovery platform for identifying secreted proteins to treat age-related diseases.

The platform brings together quantitative proteomics, machine learning, screening technologies and imaging technologies to mine the challenging landscape of secreted proteins, and determine which have therapeutic potential against aging disorders. ...